Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Deutsche Boerse AG  >  3SBio Inc. (ADR)    

3SBIO INC. (ADR)
Mes dernières consult.
Most popular
  Report  
 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials (CNY)
Sales 2018 5 027 M
EBIT 2018 1 469 M
Net income 2018 1 191 M
Debt 2018 1 117 M
Yield 2018 0,20%
Sales 2019 6 190 M
EBIT 2019 1 824 M
Net income 2019 1 514 M
Finance 2019 425 M
Yield 2019 0,26%
P/E ratio 2018 35,88
P/E ratio 2019 28,28
EV / Sales2018 8,55x
EV / Sales2019 6,69x
Capitalization 41 836 M
More Financials
Company
3SBio, Inc. operates as in investment holding company which engages in the development, production, marketing, and sale of biopharmaceutical products.It is used in the field of medicine particularly in nephrology, oncology, supportive cancer care, inflammation and infectious diseases.The company... 
Sector
Pharmaceuticals
Calendar
06/20Shareholder meeting
More about the company
Surperformance© ratings of 3SBio Inc. (ADR)
Trading Rating : Investor Rating :
More Ratings
Latest news on 3SBIO INC. (ADR)
05/02ABBVIE : Refuge raises $25M series B
AQ
05/023SBIO : to collaborate with Refuge Biotechnologies
AQ
03/273SBIO : year net up 31% to Rmb935m; div HK6.85 cts
AQ
02/233SBIO : says TPIAO granted approval for clinical trials
AQ
01/163SBIO INC : China FDA Approves New Once-Weekly Bydureon to Improve Glycemic Cont..
AQ
20173SBIO : new product approved for clinical trials
AQ
20173SBIO : Accelerates Expansion of its Global Biologics Platform by Acquiring the ..
PU
20173SBIO : Accelerates Expansion of its Global Biologics Platform by Acquiring the ..
AQ
20173SBIO : forms joint venture to buy CDMO business
AQ
20173SBIO : Therapure Biopharma Inc. Announces Spin Off and Sale of Contract Develop..
AQ
More news
Sector news : Biopharmaceuticals
02:00pSUN PHARMACEUTICAL INDUSTRIES : Pharma Consolidated Net Profit Rises 7%
DJ
12:49pALEXION : Wilson Therapeutics Holders Accept Offer
DJ
11:08aBayer cuts Monsanto synergy target by $300 million due to divestments
RE
09:29aAstraZeneca cancer drug hits second goal by extending survival
RE
08:48aPFIZER : Plans to Pay $24 Million To Settle Probe Over Medicare -- WSJ
DJ
More sector news : Biopharmaceuticals
Income Statement Evolution
Consensus
 
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 16,0  CNY
Spread / Average Target -2,6%
EPS Revisions
Managers
NameTitle
Jing Lou Chairman, President & Chief Executive Officer
Wei hong Xiao Chief Operating Officer
Bo Tan Chief Financial Officer & Executive Director
Zhenping Zhu Chief Scientific Officer
Dong Mei Su Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
3SBIO INC. (ADR)6 550
CSL LIMITED0.00%62 614
BIOGEN-10.72%60 013
ALEXION PHARMACEUTICALS-1.22%26 064
GRIFOLS3.05%18 381
BIOMARIN PHARMACEUTICAL-0.80%15 600